Compile Data Set for Download or QSAR
Report error Found 77 Enz. Inhib. hit(s) with all data for entry = 12938
TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742459(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742468(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: >5.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742467(4-fluoro-1- [2-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50:  288nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742466(4-methyl-1- [(2S)-2-(4- methylsulfonyl- piperazin-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742465(1-[2-(4-ethylsulfonyl- piperazin-1-yl) propyl]-4- ...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742464(1-[2-(4-butylsulfonyl- 1,4-diazepan-1- yl)propyl]-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742463(4-methyl-1-[(6-oxo-3- piperidyl) methyl]-5-[[2- [6...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742462(4-methyl-1-[2- (4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742461(4-methyl-1-[1- methyl-2-(4- methylsulfonyl- pipera...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742460(4-methyl-5- [[2-[6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742469(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742458(4-methyl-1-[3-(4-prop- 2-enoylpiperazin-1- yl)prop...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742457(4-methyl-1-[4-(4-prop- 2-enoylpiperazin-1- yl)buty...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742456(1-[2-(4-isopropyl- sulfonylpiperazin-1- yl)propyl]...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742455(4-methyl-1-[2-(4-prop- 2-enoylpiperazin-1- yl)prop...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742454(4-methyl-5- [[2-[6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742453(4-[7-[[2-cyano- 4-methyl-1-[[3- (sulfamoylamino)-1...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742452(1-[3-[[2-cyano-4- methyl-5- [[2-[6-(2,2,2- trifluo...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742451(N-[3-[2-cyano-4- methyl-5-[[2-[6-(2,2,2- trifluoro...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742450(4-methyl-5-[[2-[2- (methylamino)- 6-(2,2,2- triflu...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742478(N-[3-[[2-cyano-4- methyl-5-[[2-[6-(2,2,2- trifluor...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742487(4-methyl-1-[(2S)- 5-oxomorpholin-2- yl]methyl]-5-[...)
Affinity DataEC50:  750nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742486(1-[(4-ethyl-5-oxo- morpholin-2-yl) methyl]-4- meth...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742485(4-methyl-1-[(2S)-5- oxomorpholin-2- yl]methyl]-5- ...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742484(4-methyl-1-[[(2R)- 5-oxomorpholin-2- yl]methyl]-5-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742483(4-methyl-1-[[(2R,3S)- 6-oxo-2-phenyl-3- piperidyl]...)
Affinity DataEC50:  288nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742482((E)-1-(2-(4-(4- (dimethylamino)but-2- enoyl)pipera...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742481(5-((2-(6-(2,2,2- trifluoroethyl) quinazolin-4-yl)-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742480(4-methyl-1-(2- morpholinoethyl)- 5-((2-(6- (2,2,2-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742479(N-[3-[2-cyano-4- methyl-5-[2-[6-(2,2,2- trifluoroe...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742449(5-[[2-[5- fluoro-6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742477(4-methyl-1-[2-(3-oxo- piperazin-1-yl) propyl]-5- ...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742476(1-(2-(4- (methylsulfonyl) piperazin-1-yl)ethyl)- 5...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742475(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742474(4-methyl-1-[(5-oxo- 1,4-oxazepan-2- yl)methyl]-5- ...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742473(1-(2-(4-acryloyl- piperazin- 1-yl)ethyl)-5-((2-(6-...)
Affinity DataEC50:  288nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742472(4-methyl-1-[2-(4- methylsulfonyl- piperazin-1- yl)...)
Affinity DataEC50: >5.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742471(4-methyl-1-[(5- oxomorpholin-2- yl)methyl]-5- [[2-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742470(4-methyl-1- [(2S)-2-(4- methylsulfonyl- piperazin-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742420(4-methyl-1- [1-methyl-3-(4- methylsulfonyl- pipera...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742429(4-methyl-1-[(1R)- 1-methyl-2-(4- methylsulfonyl- p...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742428(4-methyl-1-[(2-oxo-4- piperidyl) methyl]-5-[[2- [6...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742427(1-[(3,3-dioxo-1,3,4- oxathiazinan- 6-yl)methyl]- 4...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742426(6-methoxy-1- [2-(4-methyl- sulfonylpiperazin-1- yl...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742425(1-[2-(4-cyclopropyl- sulfonylpiperazin-1- yl)propy...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742424(1-[2-(4-butyl- sulfonyl- piperazin-1- yl)propyl]-4...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742423(4-methyl-1-[(4- methyl-3,3-dioxo-1,3,4- oxathiazin...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742422(4-methyl-1-[(4- methyl-5-oxo- morpholin-2- yl)meth...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742421(4-methyl-1-[(6- oxo-1H-pyridin-3- yl)methyl]- 5-[[...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742430(4-methyl-1-[(1S)- 1-methyl-2-(4- methylsulfonyl- p...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 77 total ) | Next | Last >>
Jump to: